Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An announcement from Inari Medical ( (NARI) ) is now available.
Inari Medical has completed a merger with Stryker, resulting in significant changes to its corporate and financial structure. As of February 19, 2025, Inari has become a wholly owned subsidiary of Stryker, leading to the termination of its incentive and stock purchase plans and the discharge of outstanding obligations under a loan agreement. The merger also prompted Inari to notify Nasdaq about the delisting and deregistration of its shares, signaling a change in its public trading status. Furthermore, the merger led to a change in control, with new directors appointed, and modifications to executive employment agreements extending severance benefits.
More about Inari Medical
YTD Price Performance: 54.38%
Average Trading Volume: 2,317,235
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $4.68B
See more data about NARI stock on TipRanks’ Stock Analysis page.
